WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016059028) PYRAZOLINE-DERIVED COMPOUND AND ITS USE IN A WEEKLY DOSAGE REGIME AGAINST INFLAMMATION AND PAIN DERIVED FROM DEGENERATIVE JOINT DISEASE IN MAMMALS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/059028    International Application No.:    PCT/EP2015/073635
Publication Date: 21.04.2016 International Filing Date: 13.10.2015
IPC:
A61K 31/4155 (2006.01), A61P 29/00 (2006.01), A61P 19/02 (2006.01)
Applicants: ECUPHAR N.V. [BE/BE]; Legeweg 157 bus I B-8020 Ooslkamp (BE)
Inventors: HOMEDES-BEGUER, Josep; (ES).
SABATE-ELIAS, David; (ES)
Agent: OFICINA PONTI, S.L.P.; (ES)
Priority Data:
14382396.1 16.10.2014 EP
Title (EN) PYRAZOLINE-DERIVED COMPOUND AND ITS USE IN A WEEKLY DOSAGE REGIME AGAINST INFLAMMATION AND PAIN DERIVED FROM DEGENERATIVE JOINT DISEASE IN MAMMALS
(FR) COMPOSÉ DÉRIVÉ DE LA PYRAZOLINE ET SON UTILISATION SUIVANT UN SCHÉMA POSOLOGIQUE HEBDOMADAIRE CONTRE L'INFLAMMATION ET LA DOULEUR DÉRIVÉES D'UNE MALADIE ARTICULAIRE DÉGÉNÉRATIVE CHEZ LES MAMMIFÈRES
Abstract: front page image
(EN)The present invention refers to the use of the compounds E-6087 in a weekly dosage regime for the treatment of pain and inflammation associated to a degenerative joint disease such as osteoarthritis or a condition associated to any such disease such as lameness. The present invention is directed to the treatment of mammals, preferably of dogs.
(FR)La présente invention se rapporte à l'utilisation des composés E-6087 suivant un schéma posologique hebdomadaire pour le traitement de la douleur et de l'inflammation associées à une maladie articulaire dégénérative telle que l'arthrose ou un état associé à l'une quelconque de ces maladies, par exemple la claudication. La présente invention concerne le traitement des mammifères, de préférence des chiens.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)